Ghost authorship in industry-initiated randomised trials (Q21144680)

16 August 2022

5

Douglas G Altman

Douglas G

Altman

1 reference

16 August 2022

3

Helle Krogh Johansen

Helle Krogh

Johansen

1 reference

16 August 2022

2

Asbjørn Hróbjartsson

Asbjørn

Hróbjartsson

1 reference

16 August 2022

4

Mette T Haahr

Nordic Cochrane Centre

author given names

Mette T

author last names

Haahr

1 reference

16 August 2022

6

An-Wen

Chan

An-Wen Chan

1 reference

17227134

Creative Commons Attribution 4.0 International

16 August 2022

language of work or name

English

0 references

publication date

January 2007

0 references

published in

PLOS MEDICINE

0 references

volume

4

0 references

issue

1

0 references

page(s)

e19

0 references

copyright license

start time

16 January 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

When authorship fails. A proposal to make contributors accountable

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Declaration of medical writing assistance in international peer-reviewed publications

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Narrative review: the promotion of gabapentin: an analysis of internal industry documents

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Interface between authorship, industry and science in the domain of therapeutics

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

How statistical expertise is used in medical research

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Prevalence of honorary and ghost authorship in Cochrane reviews

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Uneasy alliance--clinical investigators and the pharmaceutical industry

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Ghost writing initiated by commercial companies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Redefining authorship. Drug industry is increasingly allowing employees to be named as authors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Haunted manuscripts: ghost authorship in the medical literature

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.0040019

Good publication practice for pharmaceutical companies

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769411

Constraints on publication rights in industry-initiated clinical trials

29 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/17227134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PMED.0040019

1 reference

1 reference

1 reference

17227134

1 reference